Pine Pharmaceuticals, LLC recalls Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharm
Recalled October 25, 2023 · FDA recall D-0058-2024 · Pine Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
2176 syringes
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →